French National Registry of Rare Peritoneal Surface Malignancies (RENAPE)

Civil Hospices of Lyon

Status: Unknown

Conditions: Primary Peritoneal Serous Carcinoma; Desmoplastic Small Round Cell Tumor; Appendiceal Mucinous Neoplasms; Rare Peritoneal Surface Malignancies; Diffuse Peritoneal Leiomyomatosis; Psammocarcinoma; Peritoneal Mesothelioma; Pseudomyxoma Peritonei

Treatments: Other: Non interventional

Study type: Observational

Funder types: Other

Identifiers

NCT02834169

69HCL16_0406

Details and patient eligibility

About

Despite advances in the management of and changes in clinical practice, little is known about the epidemiology, patterns of care and outcomes of rare peritoneal surface malignancies patients in France.

In order to better understand the characteristics of rare peritoneal surface malignancies and to evaluate treatment strategies, the RENAPE registry aims at the collection of data from patients presenting with a rare peritoneal surface malignancy in France. Data will be entered prospectively in a specifically designed and secured web database.

All RENAPE's centres and physicians are invited to register patients with a rare peritoneal surface malignancy diagnosis and to participate to the registry. Data will be evaluated within regular time frames, focusing on types of rare peritoneal surface malignancies, treatment modalities and patient outcomes (e.g. survival, recurrence), thereby contributing to the better understanding of these rare cancers.

Enrollment: 2,171 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients are eligible if they have a histologically proven rare peritoneal surface malignancy.

Exclusion criteria

• Histological diagnostic of peritoneal surface malignancy not confirmed
• Expected clinical follow up data not available

Trial design

2,171 participants in 7 patient groups

pseudomyxoma peritonei

Description:

Data from pseudomyxoma peritonei cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).

Treatment:

Other: Non interventional

peritoneal mesothelioma

Description:

Data from peritoneal mesothelioma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).

Treatment:

Other: Non interventional

desmoplastic small round cell tumor

Description:

Data from desmoplastic small round cell tumor cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).

Treatment:

Other: Non interventional

psammocarcinoma

Description:

Data from primary peritoneal serous carcinoma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).

Treatment:

Other: Non interventional

primary peritoneal serous carcinoma

Description:

Data from primary peritoneal serous carcinoma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).

Treatment:

Other: Non interventional

diffuse peritoneal leiomyomatosis

Description:

Data from diffuse peritoneal leiomyomatosis cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).

Treatment:

Other: Non interventional

appendiceal mucinous neoplasms

Description:

Data from appendiceal mucinous neoplasms cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).

Treatment:

Other: Non interventional